Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Firelands Regional Medical Center
103
mi
from 43215
Sandusky, OH
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Firelands Regional Medical Center
103
mi
from 43215
Sandusky, OH
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Mercy St. Vincent Medical Center
119
mi
from 43215
Toledo, OH
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Mercy St. Vincent Medical Center
119
mi
from 43215
Toledo, OH
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Oklahoma Heart Hospital
848
mi
from 43215
Oklahoma City, OK
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Oklahoma Heart Hospital
848
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Providence St. Vincent Medical Center
2031
mi
from 43215
Portland, OR
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Providence St. Vincent Medical Center
2031
mi
from 43215
Portland, OR
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Lankenau Institute for Medical Research
407
mi
from 43215
Bryn Mawr, PA
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Lankenau Institute for Medical Research
407
mi
from 43215
Bryn Mawr, PA
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Pinnacle Health @ Harrisburg Hospital
322
mi
from 43215
Harrisburg, PA
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Pinnacle Health @ Harrisburg Hospital
322
mi
from 43215
Harrisburg, PA
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Penn State Milton S. Hershey Medical Center
337
mi
from 43215
Hershey, PA
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Penn State Milton S. Hershey Medical Center
337
mi
from 43215
Hershey, PA
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Sisters of Charity Providence Hospital
425
mi
from 43215
Columbia, SC
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Sisters of Charity Providence Hospital
425
mi
from 43215
Columbia, SC
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Jackson Madison County General Hospital
431
mi
from 43215
Jackson, TN
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Jackson Madison County General Hospital
431
mi
from 43215
Jackson, TN
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Baptist Memorial Hospital
502
mi
from 43215
Memphis, TN
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Baptist Memorial Hospital
502
mi
from 43215
Memphis, TN
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Heart Hospital of Austin
1065
mi
from 43215
Austin, TX
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Heart Hospital of Austin
1065
mi
from 43215
Austin, TX
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Baylor Heart and Vascular Hospital
910
mi
from 43215
Dallas, TX
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Baylor Heart and Vascular Hospital
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
St. Luke's Episcopal Hospital
995
mi
from 43215
Houston, TX
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
St. Luke's Episcopal Hospital
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Methodist Texsan Hospital
1137
mi
from 43215
San Antonio, TX
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Methodist Texsan Hospital
1137
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Trinity Mother Frances Health System
862
mi
from 43215
Tyler, TX
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Trinity Mother Frances Health System
862
mi
from 43215
Tyler, TX
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Lynchburg General Hospital
273
mi
from 43215
Lynchburg, VA
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Lynchburg General Hospital
273
mi
from 43215
Lynchburg, VA
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Sentara Norfolk General Hospital
422
mi
from 43215
Norfolk, VA
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Sentara Norfolk General Hospital
422
mi
from 43215
Norfolk, VA
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Swedish Medical Center
2005
mi
from 43215
Seattle, WA
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Swedish Medical Center
2005
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Deaconess Medical Center
1778
mi
from 43215
Spokane, WA
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Deaconess Medical Center
1778
mi
from 43215
Spokane, WA
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Providence Health and Services - Washington
1779
mi
from 43215
Spokane, WA
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Providence Health and Services - Washington
1779
mi
from 43215
Spokane, WA
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Aspirus Heart and Vascular Institute - Research and Education
481
mi
from 43215
Wausau, WI
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Aspirus Heart and Vascular Institute - Research and Education
481
mi
from 43215
Wausau, WI
Click here to add this to my saved trials
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Monash Medical Centre
9876
mi
from 43215
Clayton,
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Monash Medical Centre
9876
mi
from 43215
Clayton,
Click here to add this to my saved trials
PAD Registry and Fitbit Sub-Study Program
The Genetic and Risk Factor Contribution to the Progression of Peripheral Artery Disease and Severe Adverse Events
Status: Enrolling
Updated:  12/31/1969
Hospital of the University of Pennsylvania
414
mi
from 43215
Philadelphia, PA
PAD Registry and Fitbit Sub-Study Program
The Genetic and Risk Factor Contribution to the Progression of Peripheral Artery Disease and Severe Adverse Events
Status: Enrolling
Updated: 12/31/1969
Hospital of the University of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
The Use of Nesiritide in Thoracic Aneurysm Repair to Prevent Acute Renal Failure
Prophylactic Use of Nesiritide (Brain Natriuretic Peptide, BNP) for the Prevention of Acute Renal Failure in Thoracic Aortic Aneurysm Surgery Patients
Status: Enrolling
Updated:  6/23/2005
Shands Hospital at the University of Florida
711
mi
from 43215
Gainesville, FL
The Use of Nesiritide in Thoracic Aneurysm Repair to Prevent Acute Renal Failure
Prophylactic Use of Nesiritide (Brain Natriuretic Peptide, BNP) for the Prevention of Acute Renal Failure in Thoracic Aortic Aneurysm Surgery Patients
Status: Enrolling
Updated: 6/23/2005
Shands Hospital at the University of Florida
711
mi
from 43215
Gainesville, FL
Click here to add this to my saved trials
Safety Study of Using Stem Cells to Stimulate Development of New Blood Vessels in Peripheral Vascular Disease
Phase I Study of Stem Cell Mediated Angiogenesis for Limb Threatening Ischemia
Status: Enrolling
Updated:  6/23/2005
Indiana University School of Medicine
166
mi
from 43215
Indianapolis, IN
Safety Study of Using Stem Cells to Stimulate Development of New Blood Vessels in Peripheral Vascular Disease
Phase I Study of Stem Cell Mediated Angiogenesis for Limb Threatening Ischemia
Status: Enrolling
Updated: 6/23/2005
Indiana University School of Medicine
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Maintaining Exercise After Cardiac Rehabilitation
Maintaining Exercise After Cardiac Rehabilitation
Status: Enrolling
Updated:  9/29/2005
Center for Cardiac Fitness
619
mi
from 43215
Providence, RI
Maintaining Exercise After Cardiac Rehabilitation
Maintaining Exercise After Cardiac Rehabilitation
Status: Enrolling
Updated: 9/29/2005
Center for Cardiac Fitness
619
mi
from 43215
Providence, RI
Click here to add this to my saved trials
Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection
A Phase I Multi-Center Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation in Patients With a Previous MI and Placement of an ICD Requiring De Novo Coronary Artery Bypass Graft Therapy
Status: Enrolling
Updated:  3/6/2006
Bioheart, Inc
968
mi
from 43215
Ft. Lauderdale, FL
Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection
A Phase I Multi-Center Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation in Patients With a Previous MI and Placement of an ICD Requiring De Novo Coronary Artery Bypass Graft Therapy
Status: Enrolling
Updated: 3/6/2006
Bioheart, Inc
968
mi
from 43215
Ft. Lauderdale, FL
Click here to add this to my saved trials
Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection
A Phase I Multi-Center Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation in Patients With a Previous MI and Placement of an ICD Requiring De Novo Coronary Artery Bypass Graft Therapy
Status: Enrolling
Updated:  3/6/2006
ACRI
427
mi
from 43215
Atlanta, GA
Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection
A Phase I Multi-Center Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation in Patients With a Previous MI and Placement of an ICD Requiring De Novo Coronary Artery Bypass Graft Therapy
Status: Enrolling
Updated: 3/6/2006
ACRI
427
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection
A Phase I Multi-Center Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation in Patients With a Previous MI and Placement of an ICD Requiring De Novo Coronary Artery Bypass Graft Therapy
Status: Enrolling
Updated:  3/6/2006
Rush-Presbyterian-St. Luke's Medical Center
277
mi
from 43215
Chicago, IL
Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection
A Phase I Multi-Center Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation in Patients With a Previous MI and Placement of an ICD Requiring De Novo Coronary Artery Bypass Graft Therapy
Status: Enrolling
Updated: 3/6/2006
Rush-Presbyterian-St. Luke's Medical Center
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection
A Phase I Multi-Center Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation in Patients With a Previous MI and Placement of an ICD Requiring De Novo Coronary Artery Bypass Graft Therapy
Status: Enrolling
Updated:  3/6/2006
Mt. Sinai Medical Center
480
mi
from 43215
New York, NY
Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection
A Phase I Multi-Center Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation in Patients With a Previous MI and Placement of an ICD Requiring De Novo Coronary Artery Bypass Graft Therapy
Status: Enrolling
Updated: 3/6/2006
Mt. Sinai Medical Center
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection
A Phase I Multi-Center Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation in Patients With a Previous MI and Placement of an ICD Requiring De Novo Coronary Artery Bypass Graft Therapy
Status: Enrolling
Updated:  3/6/2006
Duke University
352
mi
from 43215
Durham, NC
Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection
A Phase I Multi-Center Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation in Patients With a Previous MI and Placement of an ICD Requiring De Novo Coronary Artery Bypass Graft Therapy
Status: Enrolling
Updated: 3/6/2006
Duke University
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated:  6/8/2006
Cedar Sinai Department of Cardiothoracic Surgery
1978
mi
from 43215
Los Angeles, CA
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated: 6/8/2006
Cedar Sinai Department of Cardiothoracic Surgery
1978
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated:  6/8/2006
St. Joseph's Hospital
839
mi
from 43215
St. Petersburg, FL
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated: 6/8/2006
St. Joseph's Hospital
839
mi
from 43215
St. Petersburg, FL
Click here to add this to my saved trials
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated:  6/8/2006
Emory University
435
mi
from 43215
Atlanta, GA
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated: 6/8/2006
Emory University
435
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated:  6/8/2006
University of Maryland College of Medicine
343
mi
from 43215
Baltimore, MD
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated: 6/8/2006
University of Maryland College of Medicine
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated:  6/8/2006
University of Massachusetts
604
mi
from 43215
Worcester, MA
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated: 6/8/2006
University of Massachusetts
604
mi
from 43215
Worcester, MA
Click here to add this to my saved trials
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated:  6/8/2006
University of Michigan
164
mi
from 43215
Ann Arbor, MI
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated: 6/8/2006
University of Michigan
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated:  6/8/2006
NYU College of Medicine
479
mi
from 43215
New York, NY
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated: 6/8/2006
NYU College of Medicine
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated:  6/8/2006
Drexel University College of Medicine
416
mi
from 43215
Philadelphia, PA
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated: 6/8/2006
Drexel University College of Medicine
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated:  6/8/2006
University of Pennsylvania School of Medicine
414
mi
from 43215
Philadelphia, PA
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated: 6/8/2006
University of Pennsylvania School of Medicine
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated:  6/8/2006
University of Virginia College of Medicine
277
mi
from 43215
Charlottesville, VA
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart
Status: Enrolling
Updated: 6/8/2006
University of Virginia College of Medicine
277
mi
from 43215
Charlottesville, VA
Click here to add this to my saved trials
The Effects of Case Management in a Medicaid Managed Care Plan
The Effects of Case Management in a Medicaid Managed Care Plan
Status: Enrolling
Updated:  10/10/2006
Metropolitan Jewish Health System
476
mi
from 43215
Brooklyn, NY
The Effects of Case Management in a Medicaid Managed Care Plan
The Effects of Case Management in a Medicaid Managed Care Plan
Status: Enrolling
Updated: 10/10/2006
Metropolitan Jewish Health System
476
mi
from 43215
Brooklyn, NY
Click here to add this to my saved trials
Predictive Medicine Research. (PRE MED)
Predictive Medicine Research (PRE MED) :Investigation of Predictors of Health, Sub-Clinical and Clinical Organ System Diseases in Healthy Adult Population.
Status: Enrolling
Updated:  10/12/2006
Emory University Hospital
432
mi
from 43215
Atlanta, GA
Predictive Medicine Research. (PRE MED)
Predictive Medicine Research (PRE MED) :Investigation of Predictors of Health, Sub-Clinical and Clinical Organ System Diseases in Healthy Adult Population.
Status: Enrolling
Updated: 10/12/2006
Emory University Hospital
432
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Assessment of Translesional Markers and Metabolomics
An Assessment of Translesional Markers and Metabolomics
Status: Enrolling
Updated:  11/1/2006
Emory University Hospital
432
mi
from 43215
Atlanta, GA
Assessment of Translesional Markers and Metabolomics
An Assessment of Translesional Markers and Metabolomics
Status: Enrolling
Updated: 11/1/2006
Emory University Hospital
432
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
ATHERO: Advanced Technology Halting Early Re-Stenosis and Occlusion
ATHERO: Advanced Technology Halting Early Re-Stenosis and Occlusion. A Prospective Randomized Trial Comparing Silverhawk™ Atherectomy to CryoPlasty® Therapy for Lower Extremity Claudication
Status: Enrolling
Updated:  12/4/2006
University of California, San Diego Medical Center, Hillcrest
1948
mi
from 43215
San Diego, CA
ATHERO: Advanced Technology Halting Early Re-Stenosis and Occlusion
ATHERO: Advanced Technology Halting Early Re-Stenosis and Occlusion. A Prospective Randomized Trial Comparing Silverhawk™ Atherectomy to CryoPlasty® Therapy for Lower Extremity Claudication
Status: Enrolling
Updated: 12/4/2006
University of California, San Diego Medical Center, Hillcrest
1948
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Prostaglandin E1 (Liprostin) Treatment With Lower Limb Angioplasty for Peripheral Arterial Occlusive Disease
Phase II, Single Center, Non-Controlled, Open-Label Study of Liposomal Prostaglandin E1 (Liprostin) as Adjunct Therapy With Lower Limb Angioplasty in Patients With Ischemic and Non-Ischemic Peripheral Arterial Occlusive Disease
Status: Enrolling
Updated:  3/6/2007
Memorial Hermann Hospital
995
mi
from 43215
Houston, TX
Prostaglandin E1 (Liprostin) Treatment With Lower Limb Angioplasty for Peripheral Arterial Occlusive Disease
Phase II, Single Center, Non-Controlled, Open-Label Study of Liposomal Prostaglandin E1 (Liprostin) as Adjunct Therapy With Lower Limb Angioplasty in Patients With Ischemic and Non-Ischemic Peripheral Arterial Occlusive Disease
Status: Enrolling
Updated: 3/6/2007
Memorial Hermann Hospital
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Randomized Evaluation of Short-Term Rifalazil Treatment on Carotid Atherosclerosis and Intima Media Thickness
Status: Enrolling
Updated:  4/27/2007
Thoracic & Cardiovascular Healthcare Foundation
205
mi
from 43215
Lansing, MI
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Randomized Evaluation of Short-Term Rifalazil Treatment on Carotid Atherosclerosis and Intima Media Thickness
Status: Enrolling
Updated: 4/27/2007
Thoracic & Cardiovascular Healthcare Foundation
205
mi
from 43215
Lansing, MI
Click here to add this to my saved trials
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Randomized Evaluation of Short-Term Rifalazil Treatment on Carotid Atherosclerosis and Intima Media Thickness
Status: Enrolling
Updated:  4/27/2007
St. Francis Hospital
496
mi
from 43215
Roslyn, NY
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Randomized Evaluation of Short-Term Rifalazil Treatment on Carotid Atherosclerosis and Intima Media Thickness
Status: Enrolling
Updated: 4/27/2007
St. Francis Hospital
496
mi
from 43215
Roslyn, NY
Click here to add this to my saved trials
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Randomized Evaluation of Short-Term Rifalazil Treatment on Carotid Atherosclerosis and Intima Media Thickness
Status: Enrolling
Updated:  4/27/2007
Stony Brook University Medical Center
549
mi
from 43215
Stony Brook, NY
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Randomized Evaluation of Short-Term Rifalazil Treatment on Carotid Atherosclerosis and Intima Media Thickness
Status: Enrolling
Updated: 4/27/2007
Stony Brook University Medical Center
549
mi
from 43215
Stony Brook, NY
Click here to add this to my saved trials
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Randomized Evaluation of Short-Term Rifalazil Treatment on Carotid Atherosclerosis and Intima Media Thickness
Status: Enrolling
Updated:  4/27/2007
Baylor College of Medicine
991
mi
from 43215
Houston, TX
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Randomized Evaluation of Short-Term Rifalazil Treatment on Carotid Atherosclerosis and Intima Media Thickness
Status: Enrolling
Updated: 4/27/2007
Baylor College of Medicine
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials